CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES...License Agreement • May 25th, 2012 • Coronado Biosciences Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO LICENSE AGREEMENT (this “Amendment”), effective as of May 16, 2012 (the “Amendment Effective Date”), is entered into by and between Coronado Biosciences, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 15 New England Executive Park, Burlington, MA 01803 (“Coronado”), and UCL Business PLC, whose registered office is The Network Building, 97 Tottenham Court Road, London W1T 4TP United Kingdom (“UCLB”). Coronado and UCLB are each sometimes referred to herein as a “Party” and collectively referred to herein as the “Parties”.
